ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Elderly patients"

  • 2019 American Transplant Congress

    Everolimus/Low Tacrolimus Exposure versus Sodium Mycophenolate/Standard Tacrolimus for the Elderly Kidney Transplant Recipient. A 4-y Follow-Up of the nEverOld Trial

    E. David-Neto, F. Agena, F. J. Paula, N. Z. Galante, D. S. David, F. Ramos, A. K. Triboni, P. Romano, P. A. Ebner, V. Coelho, M. Altona, R. Falci, A. Piovesan, W. C. Nahas

    Renal Transplantation Service, Hospital das Clínicas - University of São Paulo School of Medicine, Sao Paulo, Brazil

    *Purpose: The standard immunosuppressive regimen used for younger patients may not be adequate for the elderly cohort.*Methods: The nEverOld is a prospective, single-center, randomized trial…
  • 2019 American Transplant Congress

    Whole Body CT Imaging in Deceased Donor Screening

    J. W. Mensink1, R. A. Pol.2, W. N. Nijboer1, J. de Jonge3, K. M. Ooms - de Vries4, M. F. van der Jagt5, M. C. van de Poll6, I. P. Alwayn1, A. E. Braat1

    1Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, 2Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands, 3Department of Surgery; Division of Transplantation, Erasmus Medical Center, Rotterdam, Netherlands, 4Dutch Transplant Foundation, Leiden, Netherlands, 5Department of Surgery; Division of Transplantation, University Medical Center St. Radboud, Nijmegen, Netherlands, 6Department of Surgery and Department of Intensive Care, Maastricht University Medical Center, Maastricht, Netherlands

    *Purpose: Using older (extended criteria) donors to increase the donor pool increases the risk of malignancies in the donor. Our aim was to analyze the…
  • 2019 American Transplant Congress

    Liver Transplant Outcomes in Patients with Atrial Fibrillation

    D. Devuni1, P. Mahboub2, P. Martins2, C. Barry1, I. Zacharias1, B. Movahedi2, G. Barnard1, A. Bozorgzadeh2

    1Division of Gastroenterology, University of Massachusetts Medical School, Worcester, MA, 2Surgery, Division of Transplantation, University of Massachusetts Medical School, Worcester, MA

    *Purpose: There is an increase in percentage of patients over the age of 65 yrs. who are being listed for liver transplantation (LT). Patients with…
  • 2019 American Transplant Congress

    Sirolimus in Geriatric Kidney Transplantation: Modification of Outcomes by Pre-Transplant History of Malignancy or Cardiovascular Disease

    H. Ibrahim1, C. Chen2, K. Alquadan3, X. Wen4, K. L. Womer3, A. H. Santos Jr1

    1College of Medicine, Div. of Nephrology, Hypertension & Renal Transplantation, Univ. of Florida, Gainesville, FL, 2College of Pharmacy, Univ. of Florida, Gainesville, FL, 3College of Medicine, Div. of Nephrology, Hypertension & Renal Transplantation, Univ. of Florida, Gainesville, FL, 4College of Pharmacy, Univ. of Rhode Island, Kingston, RI

    *Purpose: We analyzed the outcomes associated with sirolimus (SRL)-regimens in geriatric (>/=65-year-old) kidney transplant recipients (KTRs).*Methods: Using 2000-2016 Scientific Registry of Transplant Recipients data, Cox…
  • 2019 American Transplant Congress

    Infectious Complications in Kidney Transplant Recipients Age 65 and Older

    L. E. Liriano-Ward1, M. Barbachan e Silva2, Y. Azzi1, M. Ajaimy1, A. Cambell1, J. Graham1, J. Rocca1, C. Pynadath1, G. Nair1, O. Andacoglu1, S. Greenstein1, P. Ó Broin2, E. Akalin1

    1Transplant, Einstein/Montefiore Medical Center, Bronx, NY, 2School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway, Galway, Ireland

    *Purpose: Kidney transplant recipients age 65 years and older are at higher risk for development of infections. We aimed to investigate the incidence of both…
  • 2019 American Transplant Congress

    The Association of Kidney Transplant Center Volume with 3-Year Outcomes

    E. M. Sonnenberg1, J. B. Cohen2, J. Y. Hsu3, V. S. Potluri2, M. H. Levine1, P. L. Abt1, P. P. Reese2

    1Surgery, University of Pennsylvania, Philadelphia, PA, 2Renal Division, University of Pennsylvania, Philadelphia, PA, 3Biostatistics, University of Pennsylvania, Philadelphia, PA

    *Purpose: To assess if a center volume-outcome relationship exists for contemporary kidney transplantation, specifically in increased-risk scenarios including: diabetic recipients, elderly recipients (age>65) or recipients…
  • 2019 American Transplant Congress

    Delayed Graft Function as a Survival Prognostic Factor in Elderly Recipients of Kidney Transplantation

    G. J. Piñeiro, E. Guillen, P. Ventura, J. V. Torregrosa, R. Gelpi, I. Revuelta, F. Cofan, E. De Sousa, D. Cucchiari, J. Ugalde, F. Oppenheimer, F. Diekmann, N. Esforzado

    Nephrology and Kidney Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain

    *Purpose: Kidney transplantation (KT) provides advantages in terms of survival compared with dialysis. However, in elderly recipients, despite a better long-term survival, a high mortality…
  • 2019 American Transplant Congress

    Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant

    S. Anders, A. Freeman, A. Mohammed, L. Hutchinson, U. Kaszubski, M. Janusek, J. Garces, H. Bohorquez

    Ochsner Clinic Foundation, New Orleans, LA

    *Purpose: As a consequence of natural immunosenescence, elderly patients may not require as potent immunosuppression as their younger counterparts. Optimal induction regimens in this population,…
  • 2019 American Transplant Congress

    Outcomes of Reduced Thymoglobulin Induction Dosing in Elderly Kidney Transplant Recipients at a Steroid Sparing Center

    E. C. Liu, J. H. Lee, R. Abramova

    Pharmacy, NewYork-Presbyterian, New York, NY

    *Purpose: Studies have demonstrated a mortality benefit with kidney transplantation (KT) in elderly patients, but there is little consensus over optimal immunosuppression. Older KT recipients…
  • 2019 American Transplant Congress

    Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients

    C. Pham, S. Kuten, A. Rogers, R. Knight, D. T. Nguyen, E. Graviss, A. Gaber

    Houston Methodist Hospital, Houston, TX

    *Purpose: It is well recognized that elderly transplant recipients experience lower rates of acute rejection along with higher rates of infectious death compared to their…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 17
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences